Peconic Partners’s iShares Biotechnology ETF IBB Stock Holding History

Peconic Partners’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-7,500	Closed	-$985K	–	38
2022 Q4	$985K	Hold	7,500	–	–	0.06%	18
2022 Q3	$877K	Sell	7,500 -60,000	-89%	-$7.45M	0.06%	20
2022 Q2	$7.94M	Buy	67,500 +60,000	+800%	+$7.12M	0.58%	13
2022 Q1	$977K	Hold	7,500	–	–	0.07%	22
2021 Q4	$1.15M	Hold	7,500	–	–	0.09%	14
2021 Q3	$1.21M	Hold	7,500	–	–	0.11%	22
2021 Q2	$1.23M	Hold	7,500	–	–	0.12%	19
2021 Q1	$1.13M	Sell	7,500 -7,500	-50%	-$1.19M	0.12%	23
2020 Q4	$2.27M	Hold	15,000	–	–	0.27%	28
2020 Q3	$2.03M	Hold	15,000	–	–	0.36%	23
2020 Q2	$2.05M	Buy	+15,000	New	+$1.91M	0.57%	15

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Peconic Partners's IBB Position: Q1 2023 in Review

Peconic Partners sold out of iShares Biotechnology ETF (IBB) in Q1 2023, closing a stake of 7,500 shares — an estimated $985K sold.

Peconic Partners first reported a position in IBB in Q2 2020 and held it in 11 quarters. The position peaked at $7.94M in Q2 2022. 866 funds tracked by Wall St. Rank hold IBB as of Q1 2023.

Peconic Partners reported no remaining iShares Biotechnology ETF position as of Q1 2023 after selling out during the quarter.
Peconic Partners sold 7,500 iShares Biotechnology ETF shares in Q1 2023, an estimated $985K.
Peconic Partners first reported a position in iShares Biotechnology ETF in Q2 2020 and held it in 11 quarters.
Peconic Partners's iShares Biotechnology ETF position peaked at $7.94M in Q2 2022.
866 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q1 2023.

Based on Peconic Partners's 13F filing for Q1 2023, filed 15 May 2023.